Tuesday, 15 October 2019
The MCAZ Chemistry and Medical Devices laboratories are now accredited to the ISO/IEC 17025 standard through the Southern African Development Community Accreditation Service (SADCAS).
The Chemistry laboratory is accredited for Quantitative and Qualitative analysis of pharmaceutical formulations by High Performance Liquid Chromatography (HPLC) and UV-Vis Spectrophotometry. The Medical Devices laboratory is accredited for Dimensions Testing, Freedom from Holes Test, Package Seal Integrity Test and Airburst testing of male Condoms. . This is a five year accreditation cycle starting from August 2015 to August 2020.
The two laboratories were previously accredited through South African National Accreditation System (SANAS). SADCAS a subsidiarity organization of the Southern African Development Community (SADC) is a non-profit, multi-economy accreditation body whose mission is to provide credible, cost-effective accreditation services. In line with the SADC push to have a regional accreditation system which supports regional and international trade, MCAZ as a participant in regional cooperation issues enlisted for accreditation through the new body.
SADCAS, has signatory status in both International Laboratory Accreditation Cooperation (ILAC) and African Accreditation Cooperation (AFRAC) thus MCAZ accreditation is recognised both regionally and internationally. As the National Regulatory Authority, this opens up our laboratories for business at international level entrenching our vision of being an effective medicines regulator in Zimbabwe and a leading regulatory authority in the world through our accredited quality testing facilities.
In pursuit of promoting high ethical standards, the Authority has formulated a Code of Ethics for its employees and members of the Authority .The Authority believes that high ethical...
Southern African Development Community (SADC), as a region has harmonized medicines registration guidelines in the common technical document (CTD) format that were approved in January 2015. Nevertheless, the harmonization...
In line with the WHO guidelines on variations and other SRA guidelines, the EVR Division is updating the MCAZ Guidelines for submitting applications for Variations to Registered Medicines. The update...
Background The Medicines Control Authority of Zimbabwe (MCAZ) Regional Centre of Regulatory Excellence (ReCORE) in partnership with the European and Developing Countries Clinical Trials Partnership (EDCTP) is offering...
The Quality Policy of the Medicines Control Authority of Zimbabwe (MCAZ) is to ensure the provision of accurate and timeous services, continuously meet requirements of our customers and guarantee patient...
In this issue: MCAZ turns 20 years Basics of reporting Side Effects of medicines Electronic Adverse Drug Reaction Reporting For more information Please click here to download the Newsletter...
Increased Reporting from the Targeted Spontaneous Reporting (TSR) Programme Click here to download Drug Information Bulletin
Download Complementary medicines applications extension - press statement
The aims of the PV policy handbook are to firstly provide a framework for a national pharmacovigilance system in Zimbabwe. Secondly, to define the pharmacovigilance activities undertaken by the Pharmacovigilance...
The Medicines Control Authority of Zimbabwe (MCAZ) as a responsible corporate citizen runs a Scholarship Fund as part of its corporate social responsibility programmes. Click here to download the...
The approved Guidelines for Advertising and Promotion of Medicines are now available. Download the Guidelines for Advertising and Promotion of Medicines
The Medicines Control Authority of Zimbabwe is responsible for the evaluation of safety, efficacy and quality and registration of complementary medicines destined for use in Zimbabwe. Please see the documents...
The MCAZ Chemistry and Medical Devices laboratories are now accredited to the ISO/IEC 17025 standard through the Southern African Development Community Accreditation Service (SADCAS). The Chemistry laboratory is accredited for...
The ZAZIBONA process is a collaboration between national medicines regulatory authorities (NMRAs) in Botswana, Namibia, Zambia, and Zimbabwe. These are four neighbouring countries in Southern Africa which have a...